Intramyocardial bone marrow mononuclear cells versus bone marrow–derived and adipose mesenchymal cells in a rat model of dilated cardiomyopathy

Cytotherapy

Volumn 19, Issue 8, 2017, Pages 947-961

  Carmona, M Dolores ^a,b,c   Cañadillas, Sagrario ^a,b,c   Romero, Miguel ^a,b,c   Blanco, Alfonso ^c   Nogueras, Sonia ^a,b,c   Herrera, Concha ^a,b,c  

^a Hospital Universitario Reina Sofia   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

animal model; dilated cardiomyopathy; growth factor; myocardial fibers organization; neovascularization; stem cell transplantation

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; PLACEBO; VASCULOTROPIN;

ADIPOSE TISSUE CELL; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BONE MARROW DERIVED MONONUCLEAR CELL; CAPILLARY DENSITY; CELL EXPANSION; CELL ISOLATION; CELL THERAPY; CELL ULTRASTRUCTURE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FUNCTIONAL ASSESSMENT; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE OVERLOAD; HISTOLOGY; HISTOPATHOLOGY; INTRAMYOCARDIAL INJECTION; MALE; MESENCHYME CELL; NONHUMAN; PRIORITY JOURNAL; RAT; STEM CELL TRANSPLANTATION; TRANSTHORACIC ECHOCARDIOGRAPHY; ADIPOSE TISSUE; ANIMAL; BIOLOGICAL THERAPY; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CARDIAC MUSCLE; CYTOLOGY; DISEASE MODEL; ECHOCARDIOGRAPHY; HEART; INJECTION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; PHYSIOLOGY; PROCEDURES; ULTRASTRUCTURE; WISTAR RAT;

ADIPOSE TISSUE; ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CARDIOMYOPATHY, DILATED; CELL- AND TISSUE-BASED THERAPY; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; HEART; INJECTIONS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIUM; RATS, WISTAR;

EID: 85021645559     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2017.05.006     Document Type: Article

References (45)

1. Behbahan, I.S., Keating, A., Gale, R.P., Bone marrow therapies for chronic heart disease. Stem Cells 33 (2015), 3212–3227, 10.1002/stem.2080.
2. Broughton, K.M., Sussman, M.A., Empowering adult stem cells for myocardial regeneration V2.0: success in small steps. Circ Res 118 (2016), 867–880, 10.1161/CIRCRESAHA.115.305227.
3. Zwetsloot, P.P., Végh, A.M., Jansen of Lorkeers, S.J., van Hout, G.P., Currie, G.L., Sena, E.S., et al. Cardiac stem cell treatment in myocardial infarction: a systematic review and meta-analysis of preclinical studies. Circ Res 118 (2016), 1223–1232, 10.1161/CIRCRESAHA.115.307676.
4. Fischer-Rasokat, U., Assmus, B., Seeger, F.H., Honold, J., Leistner, D., Fichtlscherer, S., et al. A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1 year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy. Circ Heart Fail 2 (2009), 417–423, 10.1161/CIRCHEARTFAILURE.109.855023.
5. Seth, S., Bhargava, B., Narang, R., Ray, R., Mohanty, S., Gulati, G., et al. The ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial: a long-term follow-up study. J Am Coll Cardiol 55 (2010), 1643–1654, 10.1016/j.jacc.2009.11.070.
6. Suárez de Lezo, J., Herrera, C., Romero, M., Pan, M., Suárez de Lezo, J. Jr, Carmona, M.D., et al. Functional improvement in patients with dilated cardiomyopathy after the intracoronary infusion of autologous bone marrow mononuclear cells. Rev Esp Cardiol (Engl Ed) 66 (2013), 450–457, 10.1016/j.rec.2012.11.013.
7. Martino, H., Brofman, P., Greco, O., Bueno, R., Bodanese, L., Clausell, N., et al. Multicentre, randomized, double-blind trial of intracoronary autologous mononuclear bone marrow cell injection in non-ischaemic dilated cardiomyopathy (the dilated cardiomyopathy arm of the MiHeart study). Eur Heart J 36 (2015), 2898–2904, 10.1093/eurheartj/ehv477.
8. Hamshere, S., Arnous, S., Choudhury, T., Hamshere, S., Arnous, S., Choudhury, T., et al. Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial. Eur Heart J 36 (2015), 3061–3069, 10.1093/eurheartj/ehv390.
9. Sun, C., Chang, L., Sheu, J., Chiang, C., Lee, F., Wu, C., et al. Bone marrow–derived mononuclear cell therapy alleviates left ventricular remodeling and improves heart function in rat-dilated cardiomyopathy. Crit Care Med 37 (2009), 1197–1205, 10.1097/CCM.0b013e31819c0667.
10. Chin, S.P., Poey, A.C., Wong, C.Y., Chang, S.K., Tan, C.S., Ng, M.T., et al. Intramyocardial and intracoronary autologous bone marrow-derived mesenchymal stromal cell treatment in chronic severe dilated cardiomyopathy. Cytotherapy 13 (2011), 814–821, 10.3109/14653249.2011.574118.
11. Mushtaq, M., DiFede, D.L., Golpanian, S., Khan, A., Gomes, S.A., Mendizabal, A., et al. Rationale and Design of the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis in Dilated Cardiomyopathy (The POSEIDON-DCM Study): a phase I/II, randomized pilot study of the comparative safety and efficacy of transendocardial injection of autologous mesenchymal stem cell vs. allogeneic mesenchymal stem cells in patients with non-ischemic dilated cardiomyopathy. J Cardiovasc Transl Res 9 (2014), 769–780, 10.1007/s12265-014-9594-0.
12. Nagaya, N., Kangawa, K., Itoh, T., Iwase, T., Murakami, S., Miyahara, Y., et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112 (2005), 1128–1135, 10.1161/CIRCULATIONAHA.104.500447.
13. Chen, Y., Liu, W., Li, W., Gao, W., Autologous bone marrow mesenchymal cell transplantation improves left ventricular function in a rabbit model of dilated cardiomyopathy. Exp Mol Pathol 88 (2010), 311–315, 10.1016/j.yexmp.2009.12.002.
14. Sirui Yang, S., Piao, J., Jin, L., Zhou, Y., Does pretreatment of bone marrow mesenchymal stem cells with 5-azacytidine or double intravenous infusion improve their therapeutic potential for dilated cardiomyopathy?. Med Sci Monit Basic Res 19 (2013), 20–31 PMCID: PMC3638670.
15. Suzuki, E., Fujita, D., Takahashi, M., Oba, S., Nishimatsu, H., Adipose tissue-derived stem cells as a therapeutic tool for cardiovascular disease. World J Cardiol 7 (2015), 454–465, 10.4330/wjc.v7.i8.454.
16. Lin, Y., Leu, S., Sun, C.K., Yen, C., Kao, Y., Chang, L., et al. Early combined treatment with sildenafil and adipose-derived mesenchymal stem cells preserves heart function in rat dilated cardiomyopathy. J Transl Med 26 (2010), 8–88, 10.1186/1479-5876-8-88.
17. Mörschbächer, P.D., Alves Garcez, T.N., Paz, A.H., Magrisso, A.B., Mello, H.F., Rolim, V.M., et al. Treatment of dilated cardiomyopathy in rabbits with mesenchymal stem cell transplantation and platelet-rich plasma. Vet J 209 (2016), 180–185, 10.1016/j.tvjl.2015.11.009.
18. Gho, J.M., Kummeling, G.J., Koudstaal, S., Jansen Of Lorkeers, S.J., Doevendans, P.A., Asselbergs, F.W., et al. Cell therapy, a novel remedy for dilated cardiomyopathy? A systematic review. J Card Fail 19 (2013), 494–502, 10.1016/j.cardfail.2013.05.006.
19. Kodama, M., Matsumoto, Y., Fujiwara, M., Masani, F., Izumi, T., Shibata, A., A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol 57 (1990), 250–262 PMID 2208806.
20. Kodama, M., Hanawa, H., Saeki, M., Hosono, H., Inomata, T., Suzuki, K., et al. Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. Circ Res 75 (1994), 278–284 PMID 8033341.
21. Watanabe, K., Ohta, Y., Nakazawa, M., Higuchi, H., Hasegawa, G., Naito, M., et al. Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyopathy. Br J Pharmacol 130 (2000), 1489–1495 PMID 10928949.
22. Javazon, E.H., Colter, D.C., Schwarz, E.J., Prockop, D.J., Rat marrow stromal cells are more sensitive to plating density and expand more rapidly from single-cell-derived colonies than human marrow stromal cells. Stem Cells 19 (2001), 219–225, 10.1634/stemcells.19-3-219.
23. Ridzuan, N., Al Abbar, A., Yip, W.K., Maqbool, M., Ramasamy, R., Characterization and expression of senescence marker in prolonged passages of rat bone marrow-derived mesenchymal stem cells. Stem Cells Int, 2016, 2016, 10.1155/2016/8487264 8487264.
24. Wei, X., Du, Z., Zhao, L., Feng, D., Wei, G., He, Y., et al. IFATS collection: the conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal rats. Stem Cells 27 (2009), 478–488, 10.1634/stemcells.2008-0333.
25. Houser, S.R., Margulies, K.B., Murphy, A.M., Spinale, F.G., Francis, G.S., Prabhu, S.D., et al. Animal models of heart failure: a scientific statement from the American Heart Association. Circ Res 111 (2012), 131–150, 10.1161/RES.0b013e3182582523.
26. Yang, S., Piao, J., Jin, L., Zhou, Y., Does pretreatment of bone marrow mesenchymal stem cells with 5-azacytidine or double intravenous infusion improve their therapeutic potential for dilated cardiomyopathy?. Med Sci Monit Basic Res 19 (2013), 20–31 PMCID: PMC3638670.
27. Li, L., Xia, Y., Study of adipose tissue-derived mesenchymal stem cells transplantation for rats with dilated cardiomyopathy. Ann Thorac Cardiovasc Surg 20 (2014), 398–406 PMID 24492176.
28. Farris, A.B., Colvin, R.B., Renal interstitial fibrosis: mechanisms and evaluation. Curr Opin Nephrol Hypertens 21 (2012), 289–300, 10.1097/MNH.0b013e3283521cfa.
29. Busuioc, C.J., Popescu, F.C., Mogoşanu, G.D., Lascăr, I., Pirici, I., Pop, O.T., et al. Angiogenesis assessment in experimental third degree skin burns: a histological and immunohistochemical study. Rom J Morphol Embryol 52 (2011), 887–895 PMID 21892535.
30. Ishida, M., Tomita, S., Nakatani, T., Fukuhara, S., Hamamoto, M., Nagaya, N., et al. Bone marrow-mononuclear cell transplantation had beneficial effects on doxorubicin-induced cardiomyopathy. J Heart Lung Transplant 23 (2004), 436–445, 10.1016/S1053-2498(03)00220-1.
31. Jin, B., Luo, X.P., Ni, H.C., Li, Y., Shi, H.M., Cardiac matrix remodeling following intracoronary cell transplantation in dilated cardiomyopathic rabbits. Mol Biol Rep 6 (2010), 3037–3042, 10.1007/s11033-009-9874-y.
32. Roura, S., Planas, F., Prat-Vidal, C., Leta, R., Soler-Botija, C., Carreras, F., et al. Idiopathic dilated cardiomyopathy exhibits defective vascularization and vessel formation. Eur J Heart Fail 10 (2007), 995–1002, 10.1016/j.ejheart.2007.07.008.
33. Valgimigli, M., Rigolin, G.M., Fucili, A., Porta, M.D., Soukhomovskaia, O., Malagutti, P., et al. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation 110 (2004), 1209–1212, 10.1161/01.CIR.0000136813.89036.21.
34. Neglia, D., Michelassi, C., Trivieri, M.G., Sambuceti, G., Giorgetti, A., Pratali, L., et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 105 (2002), 186–193 PMID 11790699.
35. Roson-Burgo, B., Sanchez-Guijo, F., Del Cañizo, C., De Las Rivas, J., Insights into the human mesenchymal stromal/stem cell identity through integrative transcriptomic profiling. BMC Genomics, 17, 2016, 944, 10.1186/s12864-016-3230-0.
36. Bortolotti, F., Ukovich, L., Razban, V., Martinelli, V., Ruozi, G., Pelos, B., et al. In vivo therapeutic potential of mesenchymal stromal cells depends on the source and the isolation procedure. Stem Cell Reports, 2015, 332–339, 10.1016/j.stemcr.
37. Ranganath, S.H., Levy, O., Inamdar, M.S., Karp, J.M., Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell, 2012, 244–258, 10.1016/j.stem.2012.02.005.
38. Kodama, M., Matsumoto, Y., Fujiwara, M., Zhang, S.S., Hanawa, H., Itoh, E., et al. Characteristics of giant cells and factors related to the formation of giant cells in myocarditis. Circ Res 69 (1991), 1042–1050 PMID 1934332.
39. Karantalis, V., Hare, J.M., Use of mesenchymal stem cells for therapy of cardiac disease. Circ Res, 2015, 1413–1430, 10.1161/CIRCRESAHA.116.303614.
40. Wang, M., Zhang, G., Wang, Y., Liu, T., Zhang, Y., An, Y., et al. Crosstalk of mesenchymal stem cells and macrophages promotes cardiac muscle repair. Int J Biochem Cell Biol, 2015, 53–61, 10.1016/j.biocel.2014.11.003.
41. Singh, A., Singh, A., Sen, D., Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010–2015). Stem Cell Res Ther, 7, 2016, 82, 10.1186/s13287-016-0341-0.
42. Melief, S.M., Zwaginga, J.J., Fibbe, W.E., Roelofs, H., Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts. Stem Cells Transl Med, 2013, 455–463, 10.5966/sctm.2012-0184.
43. Mattar, P., Bieback, K., Comparing the immunomodulatory properties of bone marrow, adipose tissue, and birth-associated tissue mesenchymal stromal cells. Front Immunol, 6, 2015, 560, 10.3389/fimmu.2015.00560.
44. Russell, K.A., Chow, N.H., Dukoff, D., Gibson, T.W., LaMarre, J., Betts, D.H., et al. Characterization and immunomodulatory effects of canine adipose tissue and bone marrow-derived mesenchymal stromal cells. PLoS ONE, 11, 2016, 10.1371/journal.pone.0167442 e0167442.
45. Seth, S., Narang, R., Bhargava, B., Ray, R., Mohanty, S., Gulati, G., et al. AIIMS Cardiovascular Stem Cell Study Group. Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: clinical and histopathological results: the first-in-man ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial. J Am Coll Cardiol 48 (2006), 2350–2361, 10.1016/j.jacc.2006.07.057.